These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 11558997)
1. Use of homogeneous time-resolved fluorescence energy transfer in the measurement of nuclear receptor activation. Zhou G; Cummings R; Hermes J; Moller DE Methods; 2001 Sep; 25(1):54-61. PubMed ID: 11558997 [TBL] [Abstract][Full Text] [Related]
2. A fluorescent indicator to visualize ligand-induced receptor/coactivator interactions for screening of peroxisome proliferator-activated receptor gamma ligands in living cells. Awais M; Sato M; Umezawa Y Biosens Bioelectron; 2007 May; 22(11):2564-9. PubMed ID: 17095203 [TBL] [Abstract][Full Text] [Related]
3. Development of a homogeneous, fluorescence resonance energy transfer-based in vitro recruitment assay for peroxisome proliferator-activated receptor delta via selection of active LXXLL coactivator peptides. Drake KA; Zhang JH; Harrison RK; McGeehan GM Anal Biochem; 2002 May; 304(1):63-9. PubMed ID: 11969190 [TBL] [Abstract][Full Text] [Related]
4. Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity. Stanley TB; Leesnitzer LM; Montana VG; Galardi CM; Lambert MH; Holt JA; Xu HE; Moore LB; Blanchard SG; Stimmel JB Biochemistry; 2003 Aug; 42(31):9278-87. PubMed ID: 12899614 [TBL] [Abstract][Full Text] [Related]
5. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma. Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315 [TBL] [Abstract][Full Text] [Related]
6. A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist. Chen Q; Chen J; Sun T; Shen J; Shen X; Jiang H Anal Biochem; 2004 Dec; 335(2):253-9. PubMed ID: 15556564 [TBL] [Abstract][Full Text] [Related]
7. A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator. Seethala R; Golla R; Ma Z; Zhang H; O'Malley K; Lippy J; Cheng L; Mookhtiar K; Farrelly D; Zhang L; Hariharan N; Cheng PT Anal Biochem; 2007 Apr; 363(2):263-74. PubMed ID: 17335769 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma. Shipley JM; Waxman DJ Mol Pharmacol; 2003 Aug; 64(2):355-64. PubMed ID: 12869640 [TBL] [Abstract][Full Text] [Related]
9. Ligand-induced coactivator recruitment to peroxisome proliferator-activated receptor alpha characterized by fluorescence resonance energy transfer. Miao B; Sun S; Santomenna LD; Zhang JH; Young P; Mukherjee R Methods Enzymol; 2002; 357():180-8. PubMed ID: 12424909 [No Abstract] [Full Text] [Related]
12. Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB. Inoue I; Itoh F; Aoyagi S; Tazawa S; Kusama H; Akahane M; Mastunaga T; Hayashi K; Awata T; Komoda T; Katayama S Biochem Biophys Res Commun; 2002 Jan; 290(1):131-9. PubMed ID: 11779144 [TBL] [Abstract][Full Text] [Related]
13. A homogeneous resonance energy transfer-based assay to monitor MutS/DNA interactions. Lopez-Crapez E; Malinge JM; Gatchitch F; Casano L; Langlois T; Pugnière M; Roquet F; Mathis G; Bazin H Anal Biochem; 2008 Dec; 383(2):301-6. PubMed ID: 18824153 [TBL] [Abstract][Full Text] [Related]
14. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity. Sumanasekera WK; Tien ES; Davis JW; Turpey R; Perdew GH; Vanden Heuvel JP Biochemistry; 2003 Sep; 42(36):10726-35. PubMed ID: 12962497 [TBL] [Abstract][Full Text] [Related]
15. Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design. Togashi M; Borngraeber S; Sandler B; Fletterick RJ; Webb P; Baxter JD J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):127-37. PubMed ID: 15860255 [TBL] [Abstract][Full Text] [Related]
16. Imaging of selective nuclear receptor modulator-induced conformational changes in the nuclear receptor to allow interaction with coactivator and corepressor proteins in living cells. Awais M; Sato M; Umezawa Y Chembiochem; 2007 May; 8(7):737-43. PubMed ID: 17387660 [TBL] [Abstract][Full Text] [Related]
17. Europium cryptate-tethered ribonucleotide for the labeling of RNA and its detection by time-resolved amplification of cryptate emission. Alpha-Bazin B; Bazin H; Boissy L; Mathis G Anal Biochem; 2000 Nov; 286(1):17-25. PubMed ID: 11038268 [TBL] [Abstract][Full Text] [Related]
19. Comparison of assay technologies for a nuclear receptor assay screen reveals differences in the sets of identified functional antagonists. Wu X; Glickman JF; Bowen BR; Sills MA J Biomol Screen; 2003 Aug; 8(4):381-92. PubMed ID: 14567790 [TBL] [Abstract][Full Text] [Related]
20. A novel method for determination of the affinity of protein: protein interactions in homogeneous assays. Newton P; Harrison P; Clulow S J Biomol Screen; 2008 Aug; 13(7):674-82. PubMed ID: 18626116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]